A single-center open-label study to investigate the efficacy and safety of repeated subcutaneous injections of lanreotide Autogel in patients with acromegaly previously treated with octreotide.
OBJECTIVE: To evaluate the efficacy of lanreotide Autogel, a depot preparation of a long-acting somatostatin analogue, in patients with acromegaly who were previously treated with octreotide. METHODS: In a prospective single-center, open-label, comparative study, 13 patients were switched from octr...
Main Authors: | Kelly, P, Maher, K, Chew, S, Monson, J, Grossman, AB, Jenkins, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
A comparison of lanreotide and octreotide LAR for treatment of acromegaly.
by: Turner, H, et al.
Published: (1999) -
Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly.
by: Turner, H, et al.
Published: (1999) -
Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
by: Karavitaki, N, et al.
Published: (2008) -
Discontinuation of octreotide LAR after long term, successful treatment of patients with acromegaly: is it worth trying?
by: Ramírez, C, et al.
Published: (2012) -
Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly.
by: Turner, H, et al.
Published: (2004)